About OneOme
OneOme is a Healthcare company based in Minneapolis (United States) founded in 2014 by Troy Kopischke. Patient DNA is analyzed for drug metabolism via pharmacogenomic algorithms. OneOme has raised $2.05 million across 4 funding rounds. Its chief executive, as recorded, is Troy Kopischke. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Genetic Testing. Its legal entity is OneOme LLC. Its competitors include Invitae, Myriad Genetics and Genome Medical; 2 of its 3 listed competitors have raised funding.
Company details
OneOme analyzes patient DNA via a complex multi-gene algorithm. Its flagship product OneOme RightMed use a 22-gene panel to assess the patients capability for metabolism of common drugs by analyzing enzymatic capacity of the cytochrome (CYP) P450 family of enzymes. Conditions covered by this panel include acute migraine, allergies, Alzheimers disease, anticoagulation antiplatelet therapy, arrhythmias, bacterial infections, benign prostatic hyperplasia, cancer, chronic hepatitis C, depressionanxiety, diabetes epilepsy, gastroesophageal reflux disease (GERD), HIV, hypercholesterolemia, hypertension, migraine prophylaxis, overactive bladder, pain, psychoses, rheumatoid arthritis and sleep disorders. OneOme is a partnership of the Mayo Clinic and Invenshure, and is already in use at the Mayo Clinic Center for Individualized Medicine
- Headquarters Minneapolis, United States
- Founders Troy Kopischke
- SectorsHealthcare
- Website oneome.com
- Social LinkedIn X Facebook
- Legal Name Oneome Llc
- Total Equity Funding$2.05M (USD)
in 4 rounds
- Latest Funding Round$100K (USD), Debt – Conventional
Jun 2017
Funding Insights of OneOme
OneOme has successfully raised a total of $2.05M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $100 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.05M
- Total Rounds 4
- Last Round Debt – Conventional — $100,000
- First Round $1M
(May 2015)
All 4 funding rounds of OneOme with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $100,000 | Debt – Conventional | – | – | – |
| Sep 2016 | $1.05M | Seed | – | – | – |
| Sep 2016 | $4.2M | Debt – Conventional | – | – | – |
| May 2015 | $1M | Seed | – | – | – |
People of OneOme
14 people are tracked at OneOme (9 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Troy Kopischke | Co-Founder & CEO | Leadership |
Patrick McIntyre | CEO | Leadership |
Jamie Dupris | Senior Director of Finance | Leadership |
Manish Sharma | VP of Information Technology | Leadership |
Jamie S. Dupris, MBA | Senior Finance Director | Leadership |
Mark Babineau | Chief Financial Officer | Leadership |
Brett Miller | Vice President Of Business Development | Leadership |
Tanya Rylee | Chief Administrative Officer | Leadership |
Miriam Isaac, MBA, PMP | Director Of Program Management | Leadership |
Max Blackburn | Client Services Supervisor | Team |
Madeline Marzolf | Strategic Account Manager | Team |
Michael W. | Client Services Representative | Team |
Colin Pistulka | Business Analyst | Team |
Kelsey Cotton | Client Services | Team |
Complete people profiles for OneOme
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OneOme
3 dated milestones of OneOme across 3 years, from founding to its latest funding, stage changes and deals.
- Founded OneOme is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Debt – Conventional, of $100K.
Competitors of OneOme
OneOme has 3 listed competitors in our database, 2 of them funded. They include Invitae, Myriad Genetics and Genome Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| myriad.com | 1991 | United States | 2,700 | Molecular diagnostics and personalized medicine for cancer are developed. | ||
| genomemedical.com | 2016 | Monterey, United States | $172.98M | 84 | Genomic testing services are provided clinically and directly to consumers. |
Detailed competitors of OneOme
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of OneOme
The website of OneOme (oneome.com) receives about 4.1K visits a month.
- Monthly visits4.1K
▲ 26.3% vs previous month
Websites whose visitors overlap most with OneOme. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| arcpointlabs.com | 100% | 71.6K | #375,959 | View details | |
health.umn.edu | health.umn.edu | 91% | #5,946,223 | – | |
| castlebiosciences.com | 86% | 26.9K | #985,933 | View details | |
| oraldna.com | 84% | 7.1K | #3,709,579 | View details | |
| genomind.com | 76% | 64.1K | #547,972 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for OneOme
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as OneOme (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oneome
Complete news archive for OneOme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OneOme
OneOme was founded in 2014 and raised its 1st funding round 1 year after it was founded.
OneOme is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Troy Kopischke is the CEO of OneOme, as recorded in our data. They have also founded this company.
OneOme is a funded company, having raised a total of $2.05M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on May 2015.
OneOme analyzes patient DNA via a complex multi-gene algorithm. Its flagship product OneOme RightMed use a 22-gene panel to assess the patients capability for metabolism of common drugs by analyzing enzymatic capacity of the cytochrome (CYP) P450 family of enzymes. Conditions covered by this panel include acute migraine, allergies, Alzheimers disease, anticoagulation antiplatelet therapy, arrhythmias, bacterial infections, benign prostatic hyperplasia, cancer, chronic hepatitis C, depressionanxiety, diabetes epilepsy, gastroesophageal reflux disease (GERD), HIV, hypercholesterolemia, hypertension, migraine prophylaxis, overactive bladder, pain, psychoses, rheumatoid arthritis and sleep disorders. OneOme is a partnership of the Mayo Clinic and Invenshure, and is already in use at the Mayo Clinic Center for Individualized Medicine.
OneOme's top competitors include Myriad Genetics, Genome Medical and Invitae.
OneOme operates through Oneome Llc.